Nov 27, 2012
By:
Jennifer Markarian
GlaxoSmithKline announced its intent to increase ownership in its publicly-listed, consumer-healthcare subsidiary in India and in GlaxoSmithKline Consumer Nigeria as part of its emerging-markets investment strategy.
|
Nov 14, 2012
By:
Jennifer Markarian
The Italian Medicines Agency lifted a temporary hold on the use of Novartis seasonal influenza vaccines in Italy after affirming the vaccines' safety and efficacy.
|
Oct 30, 2012
By:
Jennifer Markarian
Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.
|
Oct 16, 2012
By:
Jennifer Markarian
New US Pharmacopeial Convention (USP) standards provide a universal approach to organizing labels for prescription containers dispensed by US pharmacists in an effort to improve patient understanding.
|
Oct 9, 2012
By:
Jennifer Markarian
Merck will close its headquarters in Whitehouse Station, NJ and relocate to its existing facility in Summit, NJ, beginning in 2014.
|
Sep 18, 2012
By:
Jennifer Markarian
Bayer expands animal health business with acquisition from Teva.
|
Sep 11, 2012
By:
Jennifer Markarian
Pfizer and Mylan have agreed on terms by which Mylan may launch its generic version of Pfizer's Detrol LA (tolterodine tartrate) extended-release capsules, pending final approval by FDA.
|
Aug 28, 2012
By:
Jennifer Markarian
The Observational Medical Outcomes Partnership (OMOP), which is managed by the Foundation, desires feedback on proposed research priorities and tasks.
|
Aug 14, 2012
By:
Jennifer Markarian
Zoetis, a subsidiary of Pfizer, filed a registration statement with the US Securities and Exchange Commission for a potential initial public offering (IPO) of Class A common stock.
|
|
